BSG Guidance

Cancer datasets and tissue pathways

The Royal College of Pathologists

Caution about the use of ulipristal acetate (Esmya)

Esmya is indicated for the pre-operative and intermittent treatment of moderate to severe symptoms of uterine fibroids in women of reproductive age. However, following reports of serious liver injury, the European Medicines Agency (EMA), and the Medicines and Healthcare products Regulatory Agency (MHRA) have issued the following advice.

BSG Position Statement - Proton pump inhibitors (PPIs) and the risk of gastric cancer

NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

TA507

Out of Hours Gastroenterology - A Position Paper (2007)

The Future of Service and Training in ERCP in the UK - A Strategy

Colonoscopic Polypectomy and Endoscopic Mucosal Resection: A Practical Guide

BSG guidance on vaccination against MAP in humans

BSG guidance on the use of faecal calprotectin testing in IBD

Sedation for Gastrointestinal Endoscopic Procedures in the Elderly: Getting Safer but Still Not Nearly Safe Enough

Guidance for Endoscopic Ultrasonography - UK EUS Users' Groups

Endoscopy Global Rating Scale

PSA Rapid Response Report Issued: Reducing risk of overdose with midazolam injection in adults

Guidance on Decontamination of Equipment for Gastrointestinal Endoscopy: 2017 Edition

BSG guidance on the use of intravenous hyoscine butylbromide (buscopan) during gastrointestinal endoscopy

NICE guidance on molecular testing strategies for Lynch syndrome in people with colorectal cancer

Rapid Colorectal Diagnostic Pathway

Test and treat for Helicobacter pylori (HP) in Dyspepsia

BSG Guidance on the Use of Biosimilar Infliximab CT-P13 in IBD

Treatment Recommendations for the management of patients with chronic HCV Infection

Loading more...